Researchers are beginning work on a double-blind randomized controlled trial to test the results of this preliminary study. A 1-hour endoscopic procedure could potentially eliminate the need for ...

Researchers have identified a mechanism underlying insulin resistance in adolescents with obesity. The findings, published in Journal of Clinical Investigation, present a targetable pathway that could ...

In type 2 diabetes, the body's ability to release insulin is impaired, which leads to high blood glucose levels. Research led ...

Although diabetes is a common condition, no cure exists yet. Current therapies can manage blood sugar levels, but they do not address insulin resistance. But now, recent research reported in ACS Nano ...

You can develop high blood sugar (hyperglycemia) with type 2 diabetes. This may mean you need to work with your doctor to update your diabetes care plan, consider insulin, or adjust your medications.

The short answer is, "When patients are hyperglycemic and cannot achieve recommended levels of control with appropriate use of lifestyle modification and oral pharmacologic treatment." Further, it ...

Researchers have revealed critical insights into how impaired mitochondrial dynamics and quality control mechanisms in skeletal muscle influence insulin sensitivity in patients with Type 2 Diabetes, ...

The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people with insulin-treated type 2 diabetes (T2D), a new randomized trial showed.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Adults with type 2 diabetes using an automated insulin ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Adults with type 2 diabetes lowered their HbA1c from ...

Aug. 26 (UPI) --The Food and Drug Administration on Monday approved Insulet's Omnipod 5 automated insulin delivery system for people with Type 2 diabetes. In 2022, the FDA signed off on the system for ...